Singapore- and Silicon Valley-based biotech company Engine Biosciences received $2.5 million from Coronet Ventures, the venture unit of US-based healthcare player Cedars-Sinai Medical Centre, last week.
Continue reading this premium story with a subscription to DealStreetAsia.
SubscribeAlready a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com